INUV vs REGN · rev $15.5M vs P/E 14, rev $4.29B
Inuvo Inc (INUV) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Inuvo Inc (INUV) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported INUV revenue for 2026-06-30 was $15.5M. Net income was -$2.1M. Revenue was up 95.0% from 2026-03-31 to 2026-06-30. INUV currently screens at market cap $20.9M.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
INUV currently screens at market cap $20.9M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the INUV and REGN stock pages for the full models.
Not investment advice.